Highlights
1 patent
About
Targeted Cancer Therapies Based on H19 Gene
Anchiano Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies to treat cancer-related diseases. Its most advanced product candidate, BC-819, is under development as a treatment for non-muscle-invasive bladder cancer. Anchiano also develops a second-generation drug, BC-821, for the systemic treatment of advanced malignant neoplasms. Preclinical studies of BC-821 have showed significant efficacy in different cancer animal models, such as metastatic lung cancer and metastatic liver cancer. AnchianoTherapeutics is a direct subsidiary of Clal Biotechnology Industries Ltd.
Identity
| Name | Anchiano Therapeutics |
|---|---|
| Slug | biocancell-therapeutics |
| Former names | BioCancell Therapeutics |
| Type / kind | startup |
| Crunchbase ID | biocancell-therapeutic-inc |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgO7j_OMIDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by Chemomab Therapeutics on Mar 2021 - closed due to acquisition |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Givat Ram, Jerusalem, Israel |
Web & social
| https://www.linkedin.com/company/33255574 | |
| Twitter / X | https://twitter.com/AnchianoTx |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsLife SciencesPharmaceuticals
Business models
B2B
Tags
cancerbiotechnologybiopharmaceuticalcell-therapybiopsytargeted-therapypharma-companies
Funding
| Total raised | $37.7M |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}